je.st
news
Tag: bio
BIO announces Everyday Superhero Contest.
2015-02-25 14:31:31| Industrial Newsroom - All News for Today
BIO announced new contest aimed at recognizing biotech superheros in patient, industry, and academic communities. Ideas for potential nominees include: a graduate student whose work in the lab has led to a new approach to treating a disease; a patient whose determination has brought attention to research being done to combat their disease; or a researcher at a start-up biotech whose ground-breaking science has created a therapy that will potentially save thousands of lives.
Tags: bio
contest
everyday
announces
BIO issues statement following Kyle Bass' IPR Petition.
2015-02-18 14:30:42| Industrial Newsroom - All News for Today
According to BIO President and CEO Jim Greenwood, patents are the lifeblood of innovative, lifesaving biotech companies. Hedge fund manager Kyle Bass has opened a new door to abuse of the US patent system, exploiting USPTO's patent challenge proceeding as part of his cynical short-selling strategy against innovative biotech companies that are delivering transformative therapies to patients in need. Congress and the USPTO should act promptly to prevent abuse of the patent system in this manner.
Tags: issues
statement
bio
bass
BIO to open nominations for George Washington Carver Award.
2015-02-18 14:30:42| Industrial Newsroom - All News for Today
Eighth annual George Washington Carver Award will recognize an individual who has made a significant contribution to building the biobased economy by applying industrial biotechnology to create sustainable and environmentally friendlier products. Award serves as lasting memorial to original vision of George Washington Carver who, over a century ago, pioneered creation and commercialization of sustainable biobased products and materials and energy derived from renewable agricultural feedstock.
Tags: open
washington
george
award
BIO Study looks at venture funding for therapeutic innovation.
2015-02-13 14:30:24| Industrial Newsroom - All News for Today
BIO released study on venture financing broken down by disease area and novelty of research from 2004–2013. Study found that 78% of U.S. venture investment for therapeutics went toward novel drug R&D, suggesting innovation is core priority for investors. Disease areas affecting large populations – Diabetes, Psychiatry, Gastrointestinal, Respiratory, and Cardiovascular – have seen decline in novel drug R&D venture funding, while rare disease funding has seen large increase over past decade.
Tags: study
bio
funding
innovation
BIO Praises Vaccine Access, Certainty, and Innovation Act of 2015.
2015-02-12 14:31:20| Industrial Newsroom - All News for Today
BIO applauded introduction of Vaccine Access, Certainty, and Innovation Act of 2015 by noting how it would stimulate new vaccine research and improve patient access. In his statement, BIO President and CEO Jim Greenwood thanked Representatives Ellmers and Butterfield "for their leadership in authoring and sponsoring this important legislation." Greenwood also expressed enthusiastic anticipation regarding further work on said bill and other components of 21st Century Cures Initiative.
Tags: access
act
bio
innovation
Sites : [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] next »